Benonisson, Hreinn <br/><br/>
CD3-Bispecific Antibody Therapy Turns Solid Tumors into Inflammatory Sites but Does Not Install Protective Memory.  [electronic resource] 

 -  Molecular cancer therapeutics  02 2019 
 - 312-322 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-18-0679  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Bispecific--administration & dosage<br/>Antigens, Neoplasm--genetics<br/>CD3 Complex--antagonists & inhibitors<br/>CD4-Positive T-Lymphocytes--drug effects<br/>CD8-Positive T-Lymphocytes--drug effects<br/>Cell Line, Tumor<br/>Female<br/>Humans<br/>Immunologic Memory<br/>Lymphocyte Activation<br/>Melanoma--drug therapy<br/>Mice<br/>Tumor Microenvironment--drug effects<br/>Xenograft Model Antitumor Assays